Jennifer Liu is a China partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. She has extensive experience advising corporate and investment banking clients on a broad range of corporate matters, including Hong Kong and U.S. initial public offerings and follow-on equity and debt offerings. Jennifer’s practice spans multiple industries, including healthcare, life sciences, technology, consumer products, and financial services.
Prior to joining the firm, Jennifer was an executive director at a top global investment bank as legal counsel in the Investment Banking and Global Capital Markets divisions. Jennifer was also a counsel in the Hong Kong office of another leading international law firm.
She is fluent in both Mandarin and English.
Jennifer Liu is a China partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. She has extensive experience advising corporate and investment banking clients on a broad range of corporate matters, including Hong Kong and U.S. initial public offerings and follow-on equity and debt offerings. Jennifer’s practice spans multiple industries, including healthcare, life sciences, technology, consumer products, and financial services.
Prior to joining the firm, Jennifer was an executive director at a top global investment bank as legal counsel in the Investment Banking and Global Capital Markets divisions. Jennifer was also a counsel in the Hong Kong office of another leading international law firm.
She is fluent in both Mandarin and English.
- LL.M., Columbia Law School, 2011
Harlan Fiske Stone Scholar
- LL.B., Peking University, 2008
- Solicitor, Hong Kong SAR
- State Bar of New York
- LL.M., Columbia Law School, 2011
Harlan Fiske Stone Scholar
- LL.B., Peking University, 2008
- Solicitor, Hong Kong SAR
- State Bar of New York
Select Matters
IPOs and follow-on offerings for companies including:
- Medtide Inc.*
- Mirxes*
- New Horizon Health*
- BrainAurora Medical Technology*
- CARsgen Therapeutics*
- Shenzhen Hepalink Pharmaceutical*
- Venus Medtech*
- Zylox-Tonbridge*
- HUTCHMED*
- I-Mab*
- Zai Lab*
- AsiaInfo Technologies*
- China Everbright Greentech*
- RDA Microelectronics*
*Denotes matters handled at another firm prior to joining Wilson Sonsini in 2026.
Select Matters
IPOs and follow-on offerings for companies including:
- Medtide Inc.*
- Mirxes*
- New Horizon Health*
- BrainAurora Medical Technology*
- CARsgen Therapeutics*
- Shenzhen Hepalink Pharmaceutical*
- Venus Medtech*
- Zylox-Tonbridge*
- HUTCHMED*
- I-Mab*
- Zai Lab*
- AsiaInfo Technologies*
- China Everbright Greentech*
- RDA Microelectronics*
*Denotes matters handled at another firm prior to joining Wilson Sonsini in 2026.
- Privacy Policy
- Terms of Use
- Accessibility